IncellDx, Inc. is a single cell diagnostic company committed to advancing Precision Medicine by offering transformative diagnostic and prognostic clinical patient information based on an innovative technology platform that enables simultaneous cell classification and single cell analysis of proteomic and genomic biomarkers.
Recognizing every cell tells a story we are dedicated to revolutionizing healthcare one cell at a time. Combining proprietary molecular diagnostics with cellular analysis, we offer diagnostic, prognostic and therapeutic clinical information for physicians to make more informed clinical decisions.
More than 450,000 new cases of cervical cancer are diagnosed each year. Our CE-IVD OncoTect® E6,E7 mRNA Kit for in vitro diagnostics is a unique quantative cell based assay that measures both mRNA E6 and E7.
IncellPREP™ Tissue Single Cell Suspension (IVD/CE-IVD)
The incellPREP system is designed to prepare single cell suspensions from fresh human-sourced tissue biopsies for subsequent in vitro diagnostic (IVD) determinations.
IncellDx & Celsee Reseach Agreement
Collaborative studies will focus on the use of circulating tumor cells (CTCs) as a biospecimen for PD-L1 quantification and as a tool for tailoring therapy in metastatic lung cancer.
IncellDx Launches OncoTect® iO® Quantitative, Single Cell PD-L1 Assay
IncellDx, Inc. announces the release of the OncoTect iO Quantitative, Single Cell PD-L1 Assay, for research use only at US College of American Pathology Meeting in San Antonio TX